Literature DB >> 17641904

Rotational acetabular osteotomy with a resection of the lateral edge of the acetabulum for the treatment of advanced coxarthrosis.

K Okano1, H Enomoto, M Osaki, H Shindo.   

Abstract

INTRODUCTION: We compared the functional and radiological results of a rotational acetabular osteotomy (RAO) with and without a resection of the lateral edge of the acetabulum. The purpose of the resection was to obtain good joint congruency.
MATERIALS AND METHODS: RAO was performed on 71 hips to treat advanced coxarthrosis caused by acetabular dysplasia. RAO without a resection (non-resection group) was performed in 54 patients (57 hips) with a median age of 43.1 years. The remaining 14 patients (14 hips), who had a median age of 44.6 years, received RAO with a resection of the lateral edge of the acetabulum (resection group).
RESULTS: The average postoperative total hip joint score was better than the average preoperative score in the non-resection group (P < 0.001), but not in the resection group. In the resection group, all hips displayed progressive osteoarthritic change and ten hips had chondrolysis of the hip joint and a collapse of the transferred acetabulum within 3 years. In the non-resection group, 15 hips showed progressive osteoarthritic change, 24 hips had no change, and 18 hips showed a decrease in the osteoarthritic stage.
CONCLUSION: Our findings demonstrated that resection of the lateral edge of the acetabulum is not a useful adjunct to the RAO procedure for the treatment of advanced coxarthrosis.

Entities:  

Mesh:

Year:  2007        PMID: 17641904     DOI: 10.1007/s00402-007-0403-y

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  1 in total

1.  Joint congruency in abduction before surgery as an indication for rotational acetabular osteotomy in early hip osteoarthritis.

Authors:  Kunihiko Okano; Kenji Yamada; Katsuro Takahashi; Hiroshi Enomoto; Makoto Osaki; Hiroyuki Shindo
Journal:  Int Orthop       Date:  2009-02-17       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.